InsiderTrades

Form 4 for BSX Boston Scientific

Accepted 2023-05-03 00:00:00 ET · period of report 2023-05-02 · accession 0001225208-23-005384 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-05-03 2023-05-02 BSX Thepaut Eric Francis Yves EVP, Pres, Eur, Mid-East, Afr S - Sale+OE $52.49 -83.4K 12.3K -87% -$4.38M
D 2023-05-03 2023-05-02 BSX Thepaut Eric Francis Yves EVP, Pres, Eur, Mid-East, Afr M - OptEx $12.89 +30.7K 95.7K +47% +$395.6K
D 2023-05-03 2023-05-02 BSX Thepaut Eric Francis Yves EVP, Pres, Eur, Mid-East, Afr M - OptEx $0.00 -30.7K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-05-02 S D 83,401 $52.49 12,268.99 D — — (F1) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $52.46 to $52.52, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
2 Common Common Stock 2023-05-02 M A 30,688 $12.89 95,669.99 D — —
3 Derivative Stock Option (Right to Buy) 2023-05-02 M D 30,688 $0.00 0 D $12.89 · — to 2024-12-01 30,688 Common Stock (F2) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on December 1, 2015, the first anniversary of the date of grant.